JAFL
KYTH

Jay A. Fishman Ltd’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Jay A. Fishman Ltd’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-34,500
Closed -$2.6M – 98
2015
Q2 		$2.6M Hold
34,500
– – 0.54% 36
2015
Q1 		$1.73M Buy
34,500
+8,000
+30% +$336K 0.36% 45
2014
Q4 		$919K Hold
26,500
– – 0.2% 61
2014
Q3 		$868K Buy
26,500
+700
+3% +$24.7K 0.19% 60
2014
Q2 		$990K Buy
25,800
+6,300
+32% +$220K 0.21% 60
2014
Q1 		$775K Hold
19,500
– – 0.17% 64
2013
Q4 		$728K Hold
19,500
– – 0.16% 66
2013
Q3 		$889K Hold
19,500
– – 0.22% 63
2013
Q2 		$527K Buy
+19,500
New +$446K 0.14% 70

Other funds holding KYTH

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Jay A. Fishman Ltd's KYTH Position: Q3 2015 in Review

Jay A. Fishman Ltd sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 34,500 shares — an estimated $2.6M sold.

Jay A. Fishman Ltd first reported a position in KYTH in Q2 2013 and held it in 9 quarters. The position peaked at $2.6M in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

  • Jay A. Fishman Ltd reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 34,500 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $2.6M.
  • Jay A. Fishman Ltd first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 9 quarters.
  • Jay A. Fishman Ltd's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.6M in Q2 2015.
  • 143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Jay A. Fishman Ltd's 13F filing for Q3 2015, filed 2 Nov 2015.